Can High Cholesterol Cause Joint Pain?

High cholesterol does appear to contribute to joint pain, and the connection runs deeper than most people realize. Over the past decade, a growing body of research has linked elevated blood lipids to cartilage breakdown, abnormal bone growth inside joints, and even disc degeneration in the spine. The relationship is not as straightforward as “cholesterol clogs arteries, so it clogs joints,” but several distinct biological pathways connect what is happening in your bloodstream to what you feel in your knees, hips, and back.

How Cholesterol Damages Cartilage

The clearest evidence tying cholesterol to joint pain comes from osteoarthritis research. A clinical study comparing 100 osteoarthritis patients undergoing knee replacement with 91 non-osteoarthritis controls found that total cholesterol and LDL levels were significantly higher in the osteoarthritis group, even after accounting for the fact that those patients also tended to have a higher body mass index and more metabolic diseases.1Nature Communications. Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting Syndecan-4 That same research team then tested what a high-cholesterol diet does to mice that had surgically induced knee injuries. The mice on the cholesterol-heavy diet developed more severe cartilage degeneration and showed increased pain responses compared to mice on a regular diet. At the molecular level, cholesterol dialed down the genes responsible for building and maintaining cartilage while cranking up the genes that break it down.

The mechanism is not simply about mechanical wear. Cholesterol appears to directly interfere with the biology of chondrocytes, the cells that produce and maintain cartilage. When these cells are bathed in excess cholesterol, they lose their ability to make the structural proteins that keep cartilage resilient. This has been observed both in living animals and in cartilage tissue grown in the lab, which means weight-bearing stress is not the only factor at play. The cholesterol itself is doing damage at a cellular level.1Nature Communications. Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting Syndecan-4

The Role of Oxidized LDL

Not all LDL cholesterol is equally harmful to joints. The real troublemaker appears to be oxidized LDL, a chemically modified form of LDL that forms when cholesterol particles react with free radicals in the body. A 2024 study found that oxidized LDL disrupts the internal recycling system of cartilage cells, essentially jamming the machinery that clears out damaged cellular components. When that cleanup system fails, the cells do not just stop working; they die through an inflammatory form of cell death that triggers further damage to surrounding tissue.2PubMed Central. Oxidized LDL Accelerates Cartilage Destruction and Inflammatory Chondrocyte Death in Osteoarthritis by Disrupting the TFEB-Regulated Autophagy-Lysosome Pathway A narrative review covering the broader literature confirms that the oxidized LDL pathway is increasingly recognized as a shared mechanism linking metabolic syndrome to osteoarthritis progression.3PubMed Central. The role of oxidation of low-density lipids in pathogenesis of osteoarthritis: A narrative review

Oxidized LDL also drives problems beyond cartilage. In animal models, cholesterol accumulation stimulated immune cells called macrophages to release signaling molecules that promote abnormal bone growth inside joints. Mice with high cholesterol or impaired LDL clearance developed roughly five to seven times more ectopic bone formation within joint ligaments and dramatically larger osteophytes (bony spurs) at the edges of the knee joint compared to controls.4PubMed Central. Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis Those osteophytes are a familiar source of pain and stiffness for anyone who has lived with osteoarthritis, and this research suggests that elevated cholesterol can accelerate their growth.

Cholesterol Crystals in Joint Fluid

There is also a more direct and dramatic way cholesterol can hurt your joints. In some cases, cholesterol literally crystallizes inside joint fluid. A review of cases spanning 14 years identified cholesterol crystals in the synovial fluid of 12 patients with persistent joint swelling. These crystal deposits drove a stubborn inflammation that did not respond well to standard treatments like draining the joint or injecting corticosteroids. Surgical removal of the inflamed joint lining was the only reliably effective intervention.5PubMed. Synovial effusions containing cholesterol crystals report of 12 patients and review Cholesterol crystal arthritis is relatively uncommon, but it is worth knowing about because it mimics other crystal-related joint diseases like gout. The presence of cholesterol crystals signals severe, ongoing inflammation rather than a one-time flare.

Beyond the Knee: Tendons and the Spine

Joint pain is not limited to what happens inside the joint capsule itself. High cholesterol also affects the tendons that connect muscles to bones and the discs that cushion the spine.

LDL can accumulate in tendons much the way it builds up inside blood vessels. In people with familial hypercholesterolemia, a genetic condition that keeps LDL levels chronically high from a young age, this buildup can eventually form visible lumps called tendon xanthomas. Even before reaching that stage, cholesterol deposits in tendons can cause pain and restricted movement. Research has shown that people with familial hypercholesterolemia walk with altered Achilles tendon mechanics, suggesting reduced efficiency that may increase injury risk.6CORDIS European Commission. The effects of hypercholesterolemia on tendon health

In the spine, the connection between cholesterol and pain involves the intervertebral discs. A retrospective analysis of 196 patients found that high total cholesterol, triglycerides, and LDL were all risk factors for intervertebral disc degeneration. The study went further, demonstrating in animal models that excess cholesterol triggers immune cells to shift into a pro-inflammatory state that accelerates disc breakdown.7PubMed Central. Excessive cholesterol accelerates intervertebral disc degeneration by promoting the polarization of M1 macrophages A separate study comparing patients with symptomatic herniated lumbar discs to matched controls found that herniation patients had significantly higher triglyceride and total cholesterol levels.8PubMed Central. Symptomatic disc herniation and serum lipid levels If you have unexplained back pain alongside high cholesterol, the two may not be unrelated.

The Subchondral Bone Connection

Underneath every joint’s cartilage layer sits a thin plate of bone called the subchondral bone. Research into metabolic syndrome and osteoarthritis has identified this bone layer as a key site where metabolic problems translate into joint disease. Dyslipidemia, insulin resistance, obesity, and high blood pressure collectively drive changes in the subchondral bone that include the formation of bone marrow lesions, which show up on MRI and are strongly associated with joint pain and cartilage loss.9PubMed Central. Metabolic syndrome and subchondral bone alterations: The rise of osteoarthritis – A review. The inflammatory environment created by these metabolic factors does not just soften cartilage from above; it erodes the structural foundation from below.

Does Fixing Cholesterol Fix the Pain?

This is where things get complicated. If high cholesterol contributes to joint damage, you might expect that lowering cholesterol with statins would protect joints. The evidence on that question is genuinely mixed. One meta-analysis found no significant association between statin use and the incidence or progression of osteoarthritis overall, though it noted that different statins may have opposite effects: atorvastatin was linked to a slight reduction in osteoarthritis risk, while rosuvastatin was associated with increased risk.10PubMed. Association between statin use and incidence or progression of osteoarthritis: meta-analysis of observational studies A separate systematic review and meta-analysis actually found that statin use was associated with a slightly higher osteoarthritis risk in adjusted estimates, with medium-high and high doses carrying the strongest association.11PubMed Central. The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis

A broader review of the literature paints a somewhat different picture depending on what outcome you measure. When researchers looked at whether osteoarthritis showed up on X-rays or progressed structurally, statin users generally fared better. But when the outcome was pain and symptoms, the results ranged from no effect to a small improvement to, paradoxically, increased pain.12PubMed Central. Prevention of Osteoarthritis Progression by Statins, Targeting Metabolic and Inflammatory Aspects: A Review Part of the confusion comes from the fact that statins themselves can cause muscle and joint pain as a side effect, making it difficult to separate drug-related symptoms from the underlying condition.10PubMed. Association between statin use and incidence or progression of osteoarthritis: meta-analysis of observational studies If you are on a statin and develop new joint pain, the culprit could be the medication, the cholesterol, or both, and your doctor may need to try switching drugs to figure out which it is.

Weight Is Not the Whole Story

A reasonable objection to all of this is that people with high cholesterol also tend to carry extra weight, and excess weight alone can cause joint pain through sheer mechanical stress. That is true, and it is an important confounding factor. But recent research has started to separate the two. A study of knee osteoarthritis patients found that elevated triglycerides and reduced HDL cholesterol were both significantly associated with worse pain scores even after statistically adjusting for body mass index.13Rheumatology Advances in Practice. Metabolic syndrome and knee osteoarthritis: associations with disease stage and pain In other words, the lipid abnormalities themselves predicted pain independently of how much the person weighed. This suggests that managing your cholesterol could matter for your joints even if your weight does not change.

The same study found that high blood pressure was also associated with worse joint pain, but that association weakened once BMI was accounted for. The lipid connections held up. This is an important distinction, because it means that among the various components of metabolic syndrome, the cholesterol-related factors appear to have the most independent relationship with how much your knees actually hurt.

The Lipid Paradox in Rheumatoid Arthritis

The relationship between cholesterol and joint inflammation runs in both directions, and this creates a confusing situation in rheumatoid arthritis. People with active rheumatoid arthritis often have paradoxically low LDL cholesterol despite carrying high cardiovascular risk. When potent anti-inflammatory treatments tamp down the disease, LDL levels actually rise. One study observed a roughly seven percent increase in LDL cholesterol after effective treatment, alongside a simultaneous improvement in HDL cholesterol function.14PubMed Central. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis

This “lipid paradox” means that a standard cholesterol panel can be misleading in someone with active inflammatory arthritis. The low LDL reading does not mean their cardiovascular risk is low; instead, systemic inflammation is consuming lipoproteins and distorting the numbers.15PubMed. The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk For practical purposes, if you have rheumatoid arthritis and your cholesterol looks reassuringly normal, it does not necessarily mean your metabolic health is fine. Your doctor may want to look at additional markers or factor in your inflammatory status when assessing cardiovascular risk.

Systemic Inflammation as the Bridge

One of the most compelling ways to understand the cholesterol-joint connection is through shared inflammatory signaling. Interleukin-6, a pro-inflammatory molecule, sits at the crossroads of cholesterol metabolism and joint disease. IL-6-driven inflammation has been implicated in both atherosclerosis and several forms of arthritis, along with osteoporosis and type 2 diabetes.16PubMed Central. The Interleukin-6 inflammation pathway from cholesterol to aging–role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases This overlap suggests that the conditions are not just coincidental companions of aging; they share a common inflammatory engine. Elevated cholesterol fuels that engine, and joints are one of the places where the damage shows up.

The Gut Microbiome Factor

An emerging line of research adds another layer. The community of microbes in your gut appears to play a role in connecting metabolic problems to joint disease. Animal studies have identified gut dysbiosis, an imbalance in the microbial ecosystem, as a causal factor in the initiation and progression of obesity-associated osteoarthritis. Gut microbes and their metabolic byproducts, including lipid-derived molecules, interact with the immune system both systemically and locally within joints.17PubMed. Gut microbiota and obesity-associated osteoarthritis This is still early-stage science, and no one should be taking specific probiotics expecting joint relief based on these findings. But it hints at a broader metabolic picture in which cholesterol, gut health, immune activation, and joint pain are all nodes in the same network rather than isolated problems.

What You Can Do With This Information

If you have both high cholesterol and unexplained or worsening joint pain, it is worth considering whether the two are connected. A few practical points follow from the research. First, addressing your lipid levels through diet, exercise, and medication (if appropriate) may have joint benefits beyond the cardiovascular ones your doctor has already told you about. The evidence is strongest for the idea that elevated cholesterol accelerates cartilage and disc degeneration over time, so the payoff is more about slowing long-term damage than relieving a flare next week.

Second, if you are on a statin and developing new joint symptoms, do not simply stop the medication. Statin-related muscle and joint complaints are real, but so is the joint damage that uncontrolled cholesterol can promote. Your doctor can help distinguish between the two and may try a different statin or adjust the dose. Third, getting your weight down will help your joints for mechanical reasons, but the research described above suggests that normalizing your lipid profile matters independently of what the scale says. Even if your weight stays the same, bringing triglycerides and LDL down may reduce the inflammatory processes that make your joints hurt.